EMA’s ETF recommends updating Covid-19 vaccines to target new LP.8.1 variant: Amsterdam, The Netherlands Monday, May 19, 2025, 10:00 Hrs [IST] European Medicines Agency’s (EMA ...

The Democracy Fund published a story that trumpeted the fact that Hodkinson had retained his licence. But it did not report ...

Singapore sees a rise in COVID-19 cases, reaching 14,200 in a week. This increase is due to waning immunity and new variants.

The spring vaccination programme began on Tuesday, April 1 and almost half a million vaccinations have been delivered so far.

The pharma company secured FDA clearance to manufacture and distribute its COVID-19 vaccine Nuvaxovid for adults and at-risk ...

Most people who get Covid today will experience only a mild illness. But some people are still at risk of severe illness and are more likely to be hospitalised with Covid . This includes older people, ...

This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S. for use, the ...

After a six-week long delay, The Food and Drug Administration (FDA) has finally approved a more traditional protein-based covid vaccine produced by pharmaceutical giant Novavax.

The U.S. Food and Drug Administration approved Novavax's Covid-19 vaccine with age restrictions after a six-week delay.

The FDA has approved the Novavax Covid-19 vaccine, but with restrictions, limiting its use to older adults and those over 12 ...

Covid shots are facing greater scrutiny from top federal health officials like RFK Jr. and the FDA's Marty Makary.

The U.S. Food and Drug Administration approved Novavax’s Covid-19 vaccine, but limited its use to older adults and people over the age of 12 with conditions that put them at risk due to the illness.